88 related articles for article (PubMed ID: 10871551)
1. Ultrastructural localization of prion proteins: physiological and pathological implications.
Fournier JG; Escaig-Haye F; Grigoriev V
Microsc Res Tech; 2000 Jul; 50(1):76-88. PubMed ID: 10871551
[TBL] [Abstract][Full Text] [Related]
2. Quantum dots and prion proteins: is this a new challenge for neurodegenerative diseases imaging?
Sobrova P; Blazkova I; Chomoucka J; Drbohlavova J; Vaculovicova M; Kopel P; Hubalek J; Kizek R; Adam V
Prion; 2013; 7(5):349-58. PubMed ID: 24055838
[TBL] [Abstract][Full Text] [Related]
3. On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications.
Inyushin M; Zayas-Santiago A; Rojas L; Kucheryavykh L
Front Immunol; 2020; 11():571083. PubMed ID: 33123145
[TBL] [Abstract][Full Text] [Related]
4. Comparison of abnormal isoform of prion protein in prion-infected cell lines and primary-cultured neurons by PrPSc-specific immunostaining.
Tanaka M; Fujiwara A; Suzuki A; Yamasaki T; Hasebe R; Masujin K; Horiuchi M
J Gen Virol; 2016 Aug; 97(8):2030-2042. PubMed ID: 27267758
[TBL] [Abstract][Full Text] [Related]
5. Do prion protein gene polymorphisms induce apoptosis in non-mammals?
Birkan T; Şahin M; Öztel Z; Balcan E
J Biosci; 2016 Mar; 41(1):97-107. PubMed ID: 26949092
[TBL] [Abstract][Full Text] [Related]
6. Prion protein as a mediator of synaptic transmission.
Steinert JR
Commun Integr Biol; 2015; 8(4):e1063753. PubMed ID: 26478992
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of prion protein induces impaired autophagic flux in neurons.
Shin HY; Park JH; Carp RI; Choi EK; Kim YS
Front Aging Neurosci; 2014; 6():207. PubMed ID: 25202268
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary implications of metal binding features in different species' prion protein: an inorganic point of view.
La Mendola D; Rizzarelli E
Biomolecules; 2014 May; 4(2):546-65. PubMed ID: 24970230
[TBL] [Abstract][Full Text] [Related]
9. Prion protein facilitates synaptic vesicle release by enhancing release probability.
Robinson SW; Nugent ML; Dinsdale D; Steinert JR
Hum Mol Genet; 2014 Sep; 23(17):4581-96. PubMed ID: 24722203
[TBL] [Abstract][Full Text] [Related]
10. Early Hippocampal Synaptic Loss Precedes Neuronal Loss and Associates with Early Behavioural Deficits in Three Distinct Strains of Prion Disease.
Hilton KJ; Cunningham C; Reynolds RA; Perry VH
PLoS One; 2013; 8(6):e68062. PubMed ID: 23840812
[TBL] [Abstract][Full Text] [Related]
11. Protease resistant protein cellular isoform (PrP(c)) as a biomarker: clues into the pathogenesis of HAND.
Megra B; Eugenin E; Roberts T; Morgello S; Berman JW
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1159-66. PubMed ID: 23616272
[TBL] [Abstract][Full Text] [Related]
12. Plasma membrane invaginations containing clusters of full-length PrPSc are an early form of prion-associated neuropathology in vivo.
Godsave SF; Wille H; Pierson J; Prusiner SB; Peters PJ
Neurobiol Aging; 2013 Jun; 34(6):1621-31. PubMed ID: 23481568
[TBL] [Abstract][Full Text] [Related]
13. Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.
Hannaoui S; Maatouk L; Privat N; Levavasseur E; Faucheux BA; Haïk S
J Virol; 2013 Mar; 87(5):2535-48. PubMed ID: 23255799
[TBL] [Abstract][Full Text] [Related]
14. Insoluble cellular prion protein and its association with prion and Alzheimer diseases.
Zou WQ; Zhou X; Yuan J; Xiao X
Prion; 2011; 5(3):172-8. PubMed ID: 21847014
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6/7-PSD-95 binding.
Carulla P; Bribián A; Rangel A; Gavín R; Ferrer I; Caelles C; Del Río JA; Llorens F
Mol Biol Cell; 2011 Sep; 22(17):3041-54. PubMed ID: 21757544
[TBL] [Abstract][Full Text] [Related]
16. Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts.
Malchiodi-Albedi F; Paradisi S; Matteucci A; Frank C; Diociaiuti M
Int J Alzheimers Dis; 2011 Feb; 2011():906964. PubMed ID: 21331330
[TBL] [Abstract][Full Text] [Related]
17. The intricate mechanisms of neurodegeneration in prion diseases.
Soto C; Satani N
Trends Mol Med; 2011 Jan; 17(1):14-24. PubMed ID: 20889378
[TBL] [Abstract][Full Text] [Related]
18. Role of prions in neuroprotection and neurodegeneration: a mechanism involving glutamate receptors?
Zamponi GW; Stys PK
Prion; 2009; 3(4):187-9. PubMed ID: 19684483
[TBL] [Abstract][Full Text] [Related]
19. Identification of an intracellular site of prion conversion.
Marijanovic Z; Caputo A; Campana V; Zurzolo C
PLoS Pathog; 2009 May; 5(5):e1000426. PubMed ID: 19424437
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of human prion diseases.
Kovacs GG; Budka H
Int J Mol Sci; 2009 Mar; 10(3):976-99. PubMed ID: 19399233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
